Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-002969-27Phase 3Terminated
Phase 3, randomised, single-blind trial of polyethylene glycol 3350 + electrolytes (2 arms), sponsored by Alfasigma. Primary endpoint: Colon cleansing efficacy. Started Sep 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-002969-27.